Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMG1 pseudogene 5 (SMG1P5) is a transcribed, unprocessed pseudogene located on chromosome 16p11.2[7]. It shares sequence homology with the protein-coding SMG1 gene, which encodes a kinase involved in the nonsense-mediated mRNA decay pathway[3]. While the parental SMG1 gene functions in mRNA surveillance and cellular stress response, SMG1P5 itself does not encode a functional protein and is not a therapeutic target. As a pseudogene, SMG1P5 may have potential regulatory roles at the RNA level, such as acting as a competitive endogenous RNA (ceRNA) to sequester microRNAs or influence RNA-binding proteins, processes increasingly recognized for their impact on gene expression and disease susceptibility in some contexts[6]. However, there are no established roles for SMG1P5 in human disease, no known drug interactions, or use as a biomarker or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SMG1 pseudogene 5 (SMG1P5).